BridgeMD
New treatment option for Refactory Warts
Official title Local Hyperthermia Combined With Topical 3% Hydrogen Peroxide for Refractory Viral Warts
ClinicalTrials.gov ID: NCT07565350
What this study is testing
What is Hydrogen Peroxide 3 % Topical Solution?
Hydrogen Peroxide 3 % Topical Solution is an investigational medicine, being studied as a potential treatment for refactory warts.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- 1. Background of the Problem Viral warts result from infection of the skin or mucous membranes by human papillomavirus (HPV).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- \- 1: Patients with a disease course of ≥2 years who have failed to respond to ≥2 treatment methods (such as topical ointments, cryotherapy, laser...
- 2: The subject or their legal guardian is able to understand and sign the informed consent form/agree to participate in the study.
You likely can't join if
- 1: The subject or their legal guardian is unable to understand and refuses to sign the informed consent form / refuses to participate in the study
- 2: Individuals allergic to local hyperthermia or hydrogen peroxide;
- 3: people with tumors or other serious diseases are unable to complete this clinical study;
- 4: Due to personal or other objective reasons, it is not possible to ensure timely treatment and follow-up.
The study team makes the final eligibility decision.
Where it's taking place
- Shenyang, Liaoning, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shenyang, Liaoning, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.